-
1
-
-
84869497712
-
Impact of the CYP4F2 p.V433M polymorphism on coumarin dose requirement: Systematic review and meta-analysis
-
Danese E, Montagnana M, Johnson JA, et al. (2012). Impact of the CYP4F2 p.V433M polymorphism on coumarin dose requirement: systematic review and meta-analysis. Clin Pharmacol Ther 92:746-56.
-
(2012)
Clin Pharmacol Ther
, vol.92
, pp. 746-756
-
-
Danese, E.1
Montagnana, M.2
Johnson, J.A.3
-
2
-
-
84888246794
-
Cytochrome P450-dependent catabolism of vitamin K: Omega-hydroxylation catalyzed by human CYP4F2 and CYP4F11
-
Edson KZ, Prasad B, Unadkat JD, et al. (2013). Cytochrome P450-dependent catabolism of vitamin K: omega-hydroxylation catalyzed by human CYP4F2 and CYP4F11. Biochemistry 52:8276-85.
-
(2013)
Biochemistry
, vol.52
, pp. 8276-8285
-
-
Edson, K.Z.1
Prasad, B.2
Unadkat, J.D.3
-
3
-
-
0036138172
-
Involvement of CYP2J2 and CYP4F12 in the metabolism of ebastine in human intestinal microsomes
-
Hashizume T, Imaoka S, Mise M, et al. (2002). Involvement of CYP2J2 and CYP4F12 in the metabolism of ebastine in human intestinal microsomes. J Pharmacol Exp Ther 300:298-304.
-
(2002)
J Pharmacol Exp Ther
, vol.300
, pp. 298-304
-
-
Hashizume, T.1
Imaoka, S.2
Mise, M.3
-
4
-
-
0034997977
-
A novel cytochrome P450 enzyme responsible for the metabolism of ebastine in monkey small intestine
-
Hashizume T, Mise M, Matsumoto S, et al. (2001). A novel cytochrome P450 enzyme responsible for the metabolism of ebastine in monkey small intestine. Drug Metab Dispos 29:798-805.
-
(2001)
Drug Metab Dispos
, vol.29
, pp. 798-805
-
-
Hashizume, T.1
Mise, M.2
Matsumoto, S.3
-
5
-
-
34548390084
-
Human cytochrome p450 family 4 enzymes: Function, genetic variation and regulation
-
Hsu MH, Savas U, Griffin KJ, Johnson EF. (2007). Human cytochrome p450 family 4 enzymes: function, genetic variation and regulation. Drug Metab Rev 39:515-38.
-
(2007)
Drug Metab Rev
, vol.39
, pp. 515-538
-
-
Hsu, M.H.1
Savas, U.2
Griffin, K.J.3
Johnson, E.F.4
-
6
-
-
79251483520
-
CYP4F enzymes are responsible for the elimination of fingolimod (FTY720), a novel treatment of relapsing multiple sclerosis
-
Jin Y, Zollinger M, Borell H, et al. (2011). CYP4F enzymes are responsible for the elimination of fingolimod (FTY720), a novel treatment of relapsing multiple sclerosis. Drug Metab Dispos 39: 191-8.
-
(2011)
Drug Metab Dispos
, vol.39
, pp. 191-198
-
-
Jin, Y.1
Zollinger, M.2
Borell, H.3
-
7
-
-
33750000583
-
Cytochrome P450 4F subfamily: At the crossroads of eicosanoid and drug metabolism
-
Kalsotra A, Strobel HW. (2006). Cytochrome P450 4F subfamily: at the crossroads of eicosanoid and drug metabolism. Pharmacol Ther 112: 589-611.
-
(2006)
Pharmacol Ther
, vol.112
, pp. 589-611
-
-
Kalsotra, A.1
Strobel, H.W.2
-
8
-
-
18344377326
-
Cloning of CYP2J2 gene and identification of functional polymorphisms
-
King LM, Ma J, Srettabunjong S, et al. (2002). Cloning of CYP2J2 gene and identification of functional polymorphisms. Mol Pharmacol 61: 840-52.
-
(2002)
Mol Pharmacol
, vol.61
, pp. 840-852
-
-
King, L.M.1
Ma, J.2
Srettabunjong, S.3
-
9
-
-
33751112296
-
Characterization of ebastine, hydroxyebastine, and carebastine metabolism by human liver microsomes and expressed cytochrome P450 enzymes: Major roles for CYP2J2 and CYP3A
-
Liu KH, Kim MG, Lee DJ, et al. (2006). Characterization of ebastine, hydroxyebastine, and carebastine metabolism by human liver microsomes and expressed cytochrome P450 enzymes: major roles for CYP2J2 and CYP3A. Drug Metab Dispos 34:1793-7.
-
(2006)
Drug Metab Dispos
, vol.34
, pp. 1793-1797
-
-
Liu, K.H.1
Kim, M.G.2
Lee, D.J.3
-
10
-
-
0036842039
-
Involvement of CYP2J2 on the intestinal first-pass metabolism of antihistamine drug, astemizole
-
Matsumoto S, Hirama T, Matsubara T, et al. (2002). Involvement of CYP2J2 on the intestinal first-pass metabolism of antihistamine drug, astemizole. Drug Metab Dispos 30:1240-5.
-
(2002)
Drug Metab Dispos
, vol.30
, pp. 1240-1245
-
-
Matsumoto, S.1
Hirama, T.2
Matsubara, T.3
-
11
-
-
66849132349
-
CYP4F2 is a vitamin K1 oxidase: An explanation for altered warfarin dose in carriers of the V433M variant
-
McDonald MG, Rieder MJ, Nakano M, et al. (2009). CYP4F2 is a vitamin K1 oxidase: an explanation for altered warfarin dose in carriers of the V433M variant. Mol Pharmacol 75:1337-46.
-
(2009)
Mol Pharmacol
, vol.75
, pp. 1337-1346
-
-
McDonald, M.G.1
Rieder, M.J.2
Nakano, M.3
-
12
-
-
84904210746
-
The revised human liver cytochrome P450 ''pie'': Absolute protein quantification of CYP4F and CYP3A enzymes using targeted quantitative proteomics
-
Michaels S, Wang MZ. (2014). The revised human liver cytochrome P450 ''pie'': absolute protein quantification of CYP4F and CYP3A enzymes using targeted quantitative proteomics. Drug Metab Dispos 42:1241-51.
-
(2014)
Drug Metab Dispos
, vol.42
, pp. 1241-1251
-
-
Michaels, S.1
Wang, M.Z.2
-
13
-
-
84863445646
-
CYP4F2 gene polymorphism as a contributor to warfarin maintenance dose in Japanese subjects
-
Nakamura K, Obayashi K, Araki T, et al. (2012). CYP4F2 gene polymorphism as a contributor to warfarin maintenance dose in Japanese subjects. J Clin Pharm Ther 37:481-5.
-
(2012)
J Clin Pharm Ther
, vol.37
, pp. 481-485
-
-
Nakamura, K.1
Obayashi, K.2
Araki, T.3
-
14
-
-
0842312531
-
Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants
-
Nelson DR, Zeldin DC, Hoffman SM, et al. (2004). Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics 14:1-18.
-
(2004)
Pharmacogenetics
, vol.14
, pp. 1-18
-
-
Nelson, D.R.1
Zeldin, D.C.2
Hoffman, S.M.3
-
15
-
-
79960023245
-
Species differences in intestinal metabolic activities of cytochrome P450 isoforms between cynomolgus monkeys and humans
-
Nishimuta H, Sato K, Mizuki Y, et al. (2011). Species differences in intestinal metabolic activities of cytochrome P450 isoforms between cynomolgus monkeys and humans. Drug Metab Pharmacokinet 26: 300-6.
-
(2011)
Drug Metab Pharmacokinet
, vol.26
, pp. 300-306
-
-
Nishimuta, H.1
Sato, K.2
Mizuki, Y.3
-
16
-
-
78651165715
-
The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature
-
Omura T, Sato R. (1964). The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J Biol Chem 239: 2370-8.
-
(1964)
J Biol Chem
, vol.239
, pp. 2370-2378
-
-
Omura, T.1
Sato, R.2
-
18
-
-
34748899687
-
Disparity in holoprotein/apoprotein ratios of different standards used for immunoquantification of hepatic cytochrome P450 enzymes
-
Perrett HF, Barter ZE, Jones BC, et al. (2007). Disparity in holoprotein/apoprotein ratios of different standards used for immunoquantification of hepatic cytochrome P450 enzymes. Drug Metab Dispos 35:1733-6.
-
(2007)
Drug Metab Dispos
, vol.35
, pp. 1733-1736
-
-
Perrett, H.F.1
Barter, Z.E.2
Jones, B.C.3
-
19
-
-
0028237729
-
Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians
-
Shimada T, Yamazaki H, Mimura M, et al. (1994). Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270:414-23.
-
(1994)
J Pharmacol Exp Ther
, vol.270
, pp. 414-423
-
-
Shimada, T.1
Yamazaki, H.2
Mimura, M.3
-
20
-
-
63449117825
-
A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose
-
Takeuchi F, McGinnis R, Bourgeois S, et al. (2009). A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose. PLoS Genet 5: e1000433.
-
(2009)
PLoS Genet
, vol.5
, pp. e1000433
-
-
Takeuchi, F.1
McGinnis, R.2
Bourgeois, S.3
-
21
-
-
84905390984
-
Immunochemical detection of cytochrome P450 enzymes in small intestine microsomes of male and female untreated juvenile cynomolgus monkeys
-
Uehara S, Murayama N, Nakanishi Y, et al. (2014). Immunochemical detection of cytochrome P450 enzymes in small intestine microsomes of male and female untreated juvenile cynomolgus monkeys. Xenobiotica 44:769-74.
-
(2014)
Xenobiotica
, vol.44
, pp. 769-774
-
-
Uehara, S.1
Murayama, N.2
Nakanishi, Y.3
-
22
-
-
80054786436
-
Immunochemical detection of cytochrome P450 enzymes in liver microsomes of 27 cynomolgus monkeys
-
Uehara S, Murayama N, Nakanishi Y, et al. (2011). Immunochemical detection of cytochrome P450 enzymes in liver microsomes of 27 cynomolgus monkeys. J Pharmacol Exp Ther 339:654-61.
-
(2011)
J Pharmacol Exp Ther
, vol.339
, pp. 654-661
-
-
Uehara, S.1
Murayama, N.2
Nakanishi, Y.3
-
23
-
-
34548640569
-
Characterization of cynomolgus monkey cytochrome P450 (CYP) cDNAs: Is CYP2C76 the only monkey-specific CYP gene responsible for species differences in drug metabolism?
-
Uno Y, Hosaka S, Matsuno K, et al. (2007). Characterization of cynomolgus monkey cytochrome P450 (CYP) cDNAs: is CYP2C76 the only monkey-specific CYP gene responsible for species differences in drug metabolism? Arch Biochem Biophys 466:98-105.
-
(2007)
Arch Biochem Biophys
, vol.466
, pp. 98-105
-
-
Uno, Y.1
Hosaka, S.2
Matsuno, K.3
-
24
-
-
79954557245
-
Macaque cytochromes P450: Nomenclature, transcript, gene, genomic structure, and function
-
Uno Y, Iwasaki K, Yamazaki H, Nelson DR. (2011a). Macaque cytochromes P450: nomenclature, transcript, gene, genomic structure, and function. Drug Metab Rev 43:346-61.
-
(2011)
Drug Metab Rev
, vol.43
, pp. 346-361
-
-
Uno, Y.1
Iwasaki, K.2
Yamazaki, H.3
Nelson, D.R.4
-
25
-
-
79955749544
-
Cynomolgus macaque CYP4 isoforms are functional, metabolizing arachidonic acid
-
Uno Y, Matsuno K, Nakamura C, et al. (2011b). Cynomolgus macaque CYP4 isoforms are functional, metabolizing arachidonic acid. J Vet Med Sci 73:487-90.
-
(2011)
J Vet Med Sci
, vol.73
, pp. 487-490
-
-
Uno, Y.1
Matsuno, K.2
Nakamura, C.3
-
26
-
-
76149140867
-
Genetic variants of CYP3A4 and CYP3A5 in cynomolgus and rhesus macaques
-
Uno Y, Matsushita A, Osada N, et al. (2010). Genetic variants of CYP3A4 and CYP3A5 in cynomolgus and rhesus macaques. Drug Metab Dispos 38:209-14.
-
(2010)
Drug Metab Dispos
, vol.38
, pp. 209-214
-
-
Uno, Y.1
Matsushita, A.2
Osada, N.3
-
27
-
-
80053346683
-
CpG site degeneration triggered by the loss of functional constraint created a highly polymorphic macaque drug-metabolizing gene, CYP1A2
-
Uno Y, Osada N. (2011). CpG site degeneration triggered by the loss of functional constraint created a highly polymorphic macaque drug-metabolizing gene, CYP1A2. BMC Evol Biol 11:283.
-
(2011)
BMC Evol Biol
, vol.11
, pp. 283
-
-
Uno, Y.1
Osada, N.2
-
28
-
-
58149478521
-
A null allele impairs function of CYP2C76 gene in cynomolgus monkeys: A possible genetic tool for generation of a better animal model in drug metabolism
-
Uno Y, Sakuraba H, Uehara S, et al. (2009). A null allele impairs function of CYP2C76 gene in cynomolgus monkeys: a possible genetic tool for generation of a better animal model in drug metabolism. Drug Metab Dispos 37:14-17.
-
(2009)
Drug Metab Dispos
, vol.37
, pp. 14-17
-
-
Uno, Y.1
Sakuraba, H.2
Uehara, S.3
-
29
-
-
35548936928
-
Human enteric microsomal CYP4F enzymes O-demethylate the antiparasitic prodrug pafurami-dine
-
Wang MZ, Wu JQ, Bridges AS, et al. (2007). Human enteric microsomal CYP4F enzymes O-demethylate the antiparasitic prodrug pafurami-dine. Drug Metab Dispos 35:2067-75.
-
(2007)
Drug Metab Dispos
, vol.35
, pp. 2067-2075
-
-
Wang, M.Z.1
Wu, J.Q.2
Bridges, A.S.3
-
30
-
-
0030063499
-
Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart
-
Wu S, Moomaw CR, Tomer KB, et al. (1996). Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart. J Biol Chem 271:3460-8.
-
(1996)
J Biol Chem
, vol.271
, pp. 3460-3468
-
-
Wu, S.1
Moomaw, C.R.2
Tomer, K.B.3
-
31
-
-
33845712373
-
Inter-individual variation of cytochrome P4502J2 expression and catalytic activities in liver microsomes from Japanese and Caucasian populations
-
Yamazaki H, Okayama A, Imai N, et al. (2006). Inter-individual variation of cytochrome P4502J2 expression and catalytic activities in liver microsomes from Japanese and Caucasian populations. Xenobiotica 36:1201-9.
-
(2006)
Xenobiotica
, vol.36
, pp. 1201-1209
-
-
Yamazaki, H.1
Okayama, A.2
Imai, N.3
|